Insulin aspart, recombinant Subcutaneous and NanoVM 4-8 Years
Determining the interaction of Insulin aspart, recombinant Subcutaneous and NanoVM 4-8 Years and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: multivitamin with iron
Brand name: Fero-Folic 500, Theragran Hematinic, Ultra Enerforce
Synonyms: Multivitamin with iron, Polysaccharide-Iron Complex, Vitamin B12, and Folic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Naphazoline
- Insulin aspart, recombinant Subcutaneous-Naphazoline and Antazoline (Ophthalmic)
- Insulin aspart, recombinant Subcutaneous-Naphazoline and Pheniramine
- Insulin aspart, recombinant Subcutaneous-Naphazoline and pheniramine ophthalmic
- Insulin aspart, recombinant Subcutaneous-Naphazoline Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Naphazoline nasal
- NanoVM 4-8 Years-Insulin degludec
- NanoVM 4-8 Years-Insulin Degludec (U-100) Prefilled Pens
- NanoVM 4-8 Years-Insulin Degludec (U-100) Vials
- NanoVM 4-8 Years-Insulin Degludec (U-200) Prefilled Pens
- NanoVM 4-8 Years-Insulin degludec and liraglutide
- NanoVM 4-8 Years-Insulin degludec and liraglutide Subcutaneous